What is Imilecleucel-T?

Category: Prescription Drugs

Most popular types: Tovaxin Tcelna


Imilecleucel-T is the generic in Tcelna (which was formerly called Tovaxin). It is a type of personalized T-cell immunotherapy being studied for the treatment of Secondary Progressive Multiple Sclerosis.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 2

Commonly reported side effects and conditions associated with Imilecleucel-T

Side effect Patients Percentage

Why patients stopped taking Imilecleucel-T

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 3
Other 1
See all 3 patients who've stopped taking Imilecleucel-T


Stopped taking Imilecleucel-T

Duration Patients Percentage
6 months - 1 year 1
1 - 2 years 2
Adherence Evaluations Percentage
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 1
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 2
Not specified 0
Last updated:
There are no evaluations for Imilecleucel-T.